fig1

AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?

Figure 1. AdipoRon-mediated mechanisms and potential interconnection points to overcome gemcitabine resistance in PDAC. Schematic representation of the main metabolic and signaling pathways regulated by AdipoRon in PDAC cells. Red arrows indicate direct and indirect AdipoRon-related ways to hinder chemotherapy resistance.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/